# Cocrystal Pharma, Inc.: filings

COCP · Nasdaq · CIK 1412486 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cocp.md) · [Financials](/companies/cocp/financials.md) · [Filings](/companies/cocp/filings.md) · [Insiders](/companies/cocp/insiders.md)

## Reports and events: 345 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 219, 4 117, 10-Q 53, UPLOAD 26, CORRESP 24, 3 21, 10-K 18, D 17, 424B5 16, DEF 14A 12, SC 13G/A 12, 8-K/A 10, DEFA14A 9, SC 13G 9, EFFECT 8, PRE 14A 8, S-1/A 8, 10-K/A 7, NT 10-K 7, 10-Q/A 6, NT 10-Q 6, S-3 6, S-3/A 4, SC 13D/A 4, CT ORDER 3, SC 13D 3, SCHEDULE 13D/A 3, 424B3 2, S-1 2, S-8 2, 144 1, 424B7 1, 4/A 1, 5 1, 8-A12B 1, 8-A12G 1, CERT 1, DEF 14C 1, NT 10-Q/A 1, POS AM 1, PRE 14C 1, RW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-09 | 08:00 ET | [8-K](/filings/0001493152-26-041877.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041877 |
| 2026-08-18 | 16:30 ET | [8-K](/filings/0001493152-26-039023.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-039023 |
| 2026-08-17 | 16:15 ET | [8-K](/filings/0001493152-26-038747.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-038747 |
| 2026-08-13 | 07:29 ET | [10-Q](/filings/0001493152-26-037573.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037573 |
| 2026-08-07 | 17:11 ET | [SCHEDULE 13D/A](/filings/0001493152-26-036650.md) | Ownership report, active investor, amended | 0001493152-26-036650 |
| 2026-08-03 | 07:15 ET | [8-K](/filings/0001493152-26-035743.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035743 |
| 2026-07-17 | 08:00 ET | [8-K](/filings/0001493152-26-033662.md) | 5.07 Shareholder vote results | 0001493152-26-033662 |
| 2026-06-09 | 07:00 ET | [8-K](/filings/0001493152-26-027837.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-027837 |
| 2026-06-03 | 07:00 ET | [8-K](/filings/0001493152-26-026965.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026965 |
| 2026-05-27 | 16:30 ET | [DEF 14A](/filings/0001493152-26-025428.md) | Proxy statement, period 2026-05-27 | 0001493152-26-025428 |
| 2026-05-26 | 08:30 ET | [8-K](/filings/0001493152-26-025172.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-025172 |
| 2026-05-15 | 08:30 ET | [10-Q](/filings/0001493152-26-023377.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023377 |
| 2026-04-30 | 16:30 ET | [8-K](/filings/0001493152-26-020586.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-020586 |
| 2026-04-02 | 08:30 ET | [8-K](/filings/0001493152-26-014819.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-014819 |
| 2026-03-31 | 08:30 ET | [10-K](/filings/0001493152-26-013838.md) | Annual report, period 2025-12-31 | 0001493152-26-013838 |
| 2026-03-31 | 08:30 ET | [8-K](/filings/0001493152-26-013837.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013837 |
| 2026-03-13 | 16:30 ET | [8-K](/filings/0001493152-26-010071.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-010071 |
| 2026-03-09 | 08:30 ET | [8-K](/filings/0001493152-26-009309.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009309 |
| 2026-02-19 | 08:30 ET | [8-K](/filings/0001493152-26-007430.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-007430 |
| 2026-01-15 | 16:10 ET | [8-K](/filings/0001493152-26-002422.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-002422 |
| 2025-12-18 | 09:00 ET | [8-K](/filings/0001493152-25-028296.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-028296 |
| 2025-12-01 | 16:30 ET | [8-K](/filings/0001493152-25-025568.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025568 |
| 2025-11-14 | 08:30 ET | [8-K](/filings/0001493152-25-022603.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022603 |
| 2025-11-14 | 08:00 ET | [10-Q](/filings/0001493152-25-022581.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022581 |
| 2025-10-30 | 16:42 ET | [SCHEDULE 13D/A](/filings/0001493152-25-020250.md) | Ownership report, active investor, amended | 0001493152-25-020250 |
| 2025-10-30 | 08:00 ET | [8-K](/filings/0001493152-25-020143.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020143 |
| 2025-10-27 | 14:03 ET | [8-K](/filings/0001493152-25-019706.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-019706 |
| 2025-10-02 | 18:29 ET | [SCHEDULE 13D/A](/filings/0001493152-25-016751.md) | Ownership report, active investor, amended | 0001493152-25-016751 |
| 2025-09-19 | 16:30 ET | [S-1](/filings/0001493152-25-014266.md) | Registration statement | 0001493152-25-014266 |
| 2025-09-15 | 16:35 ET | [8-K](/filings/0001493152-25-013495.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-013495 |
| 2025-09-12 | 17:30 ET | [8-K](/filings/0001641172-25-027247.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-027247 |
| 2025-09-12 | 17:30 ET | [8-K](/filings/0001641172-25-027246.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-027246 |
| 2025-08-14 | 08:01 ET | [10-Q](/filings/0001641172-25-023728.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023728 |
| 2025-08-14 | 08:00 ET | [8-K](/filings/0001641172-25-023727.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023727 |
| 2025-08-05 | 08:31 ET | [8-K](/filings/0001641172-25-022153.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-022153 |
| 2025-07-10 | 16:30 ET | [8-K](/filings/0001641172-25-018600.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-018600 |
| 2025-07-01 | 16:30 ET | [8-K](/filings/0001641172-25-017370.md) | 5.07 Shareholder vote results | 0001641172-25-017370 |
| 2025-06-18 | 16:01 ET | [8-K](/filings/0001641172-25-015571.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-015571 |
| 2025-06-05 | 15:15 ET | [8-K](/filings/0001641172-25-013776.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013776 |
| 2025-05-29 | 08:30 ET | [8-K](/filings/0001641172-25-012791.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-012791 |
| 2025-05-15 | 08:30 ET | [8-K](/filings/0001641172-25-010537.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010537 |
| 2025-05-15 | 08:30 ET | [10-Q](/filings/0001641172-25-010539.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010539 |
| 2025-05-05 | 16:30 ET | [DEF 14A](/filings/0001641172-25-008692.md) | Proxy statement, period 2025-05-05 | 0001641172-25-008692 |
| 2025-04-24 | 08:00 ET | [8-K](/filings/0001641172-25-005944.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-005944 |
| 2025-04-23 | 17:00 ET | [8-K](/filings/0001641172-25-005876.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-005876 |
| 2025-04-08 | 16:30 ET | [8-K](/filings/0001641172-25-003232.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-003232 |
| 2025-04-01 | 16:30 ET | [8-K](/filings/0001641172-25-002088.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002088 |
| 2025-03-31 | 08:30 ET | [10-K](/filings/0001641172-25-001496.md) | Annual report, period 2024-12-31 | 0001641172-25-001496 |
| 2025-03-31 | 08:30 ET | [8-K](/filings/0001641172-25-001494.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001494 |
| 2025-01-13 | 08:00 ET | [8-K](/filings/0001493152-25-001870.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-001870 |

Page 1 of 7. [Older](/companies/cocp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.